Home > Report Information

Alzheimer's Disease Clinical Trial Monitoring Brief

Austin Research Group
October 1, 2007
SKU: ARSG1562495

Abstract Table of Contents Search inside this report Related Reports

Austin Research Group’s Trial TRAX Clinical Intelligence Monitoring series provides detailed compilations and analysis of ongoing clinical studies within a specific therapeutic area or indication. Additionally, the Trial TRAX briefs contain synthesized background information on the profiled-disease; typically includes top-line information on:

Epidemiology
Patient Segmentation
Clinical endpoints

The Trial TRAX brief also contains analysis of the clinical landscape with assessments including:

% utilization of key clinical endpoints
Number of ongoing trials (by phase of development)
Key companies sponsoring clinical trials

The main body of the brief presents key data points from competitor clinical trials in a matrix format, enabling decision-makers the ability to quickly recall and analyze information on competitor studies. The brief’s reference-guide format is designed to provide decision makers with easy access to key intelligence on competitive clinical development programs. Primary data points include:

Study Drug
Mechanism of Action
Company-Sponsor
Phase of Development
Number of Patients
Study Design
Primary Endpoints
Study Start Date

Clients utilize the Trial TRAX briefing reports to:

Monitor clinical development programs of competitors
Quickly evaluate depth and breadth of competitive landscape
Easy-to-use reference guide for analyzing competitor clinical trials
Identify potential patient recruitment challenges
Benchmark competitor clinical trial designs

Additional Information

Companies mentioned in the report:

Eli Lilly
GlaxoSmithKline
Merck
Novartis
Pfizer
Wyeth

Alzheimer's Disease Clinical Trial Monitoring Brief

Share this report

Other tasks

Research Assistance

Related Markets

CNS/Neurology Reports

Free Alert Me service